Chemotherapy

Best Practice and Research: Clinical Gastroenterology

Volumn 19, Issue 4 SPEC. ISS., 2005, Pages 649-656

  Arnold, R ^a   Rinke, A ^a   Schmidt, Ch ^a   Hofbauer, L ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Chemotherapy; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Neuroendocrine carcinoma; Poorly differentiated tumours; Streptozocin; Well differentiated tumours

Indexed keywords

ALPHA INTERFERON; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CHLOROZOTOCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; PACLITAXEL; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC;

ALOPECIA; ANTINEOPLASTIC ACTIVITY; APPENDIX TUMOR; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CARCINOID SYNDROME; CECUM TUMOR; CLINICAL TRIAL; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; DUODENUM TUMOR; GASTROINTESTINAL TUMOR; HEART FAILURE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; NAUSEA; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PREDICTION; QUALITY OF LIFE; SENSORY NEUROPATHY; SMALL INTESTINE TUMOR; STOMACH TUMOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; VOMITING; CARCINOMA; CELL DIFFERENTIATION; PANCREAS TUMOR; PATHOLOGY; REVIEW;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NEUROENDOCRINE; CELL DIFFERENTIATION; DACARBAZINE; DISEASE PROGRESSION; GASTROINTESTINAL NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS; STREPTOZOCIN;

EID: 26844562042     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2005.04.004     Document Type: Review

References (30)

1. R. Arnold B. Simon & M. Wied Treatment of neuroendocrine GEP tumours with somatostatin analogues Digestion 62 supplement 1 2000 84-91
2. J.D. Godwin Carcinoid tumors: An analysis of 2837 cases Cancer 36 1975 560-569
3. E.D. Williams & M. Sandler The classification of carcinoid tumors Lancet 75 1963 140-146
4. I.M. Modlin K.D. Lye & M. Kidd A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 4 2003 934-959
5. G. Rindi C. Bordi S. Rappel et al. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior World J Surg 20 2 1996 168-172
6. Kvols L, Perry R, Vinik A, et al. Neoplasms of the neuroendocrine system and neoplasms of the gastroenteropancreatic endocrine system. In: Cancer Medicine, 5th edn. London: Decker, 2000, pp 1121-1172.
7. J.J. Varva C. DeBoer A. Dietz et al. Streptozocin, a new antibacterial antibiotic Antibiot Annu 7 1959-60 230-235
8. F.R. White Streptozocin Cancer Chemother Rep 30 1963 49-53
9. N. Rakieten M.L. Rakieten & M.V. Nadkarni Studies on the diabetogenic action of streptozocin (NSC-37917) Cancer Chemother Rep 29 1963 91-98
10. J.S. Evans G.C. Gerritsen K.M. Mann et al. Antitumor and hyperglycemic activity of streptozocin (NSC-37917) and its cofactor, U-15 774 Cancer Chemother Rep 48 1965 1-6
11. I.M. Murray-Lyon A.L.W.F. Eddleston R. Williams et al. Treatment of a multiple-hormone-producing malignant islet-cell tumor with streptozocin Lancet 2 1968 895-898
12. L.E. Broder & S.K. Carter Pancreatic islet cell carcinoma. II. Results of therapy with streptozocin in 52 patients Ann Intern Med 79 1973 108-118
13. A. Gefel E. Flatau E. Ayalon et al. Malignant metastatic insulinoma treated with streptozocin. Report of a case and review of literature Clin Endocrinol 4 1975 461-468
14. P.S. Schein M.J. O'Conell J. Bloom et al. Clinical antitumor activity and toxicity of streptozocin (NSC-85998) Cancer 34 1974 993-1000
15. C.G. Moertel J.A. Hanley & L.A. Johnson Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma N Engl J Med 303 1980 1189-1194
16. R.B. Weiss Streptozocin: A review of its pharmacology, efficacy, and toxicity Cancer Treat Rep 66 3 1982 427-438
17. C.G. Moertel M. Lefkopoulo S. Lipsitz et al. Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet cell carcinoma N Engl J Med 326 8 1992 519-523
18. T. Von Schrenck J.M. Howard J.L. Doppman et al. Prospective study of chemotherapy in patients with metastatic gastrinoma Gastroenterology 94 6 1988 1326-1334
19. G.M. Strauss S.A. Weitzman & T.T. Aoki Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma Ann Intern Med 90 1 1979 57-58
20. A. Kessinger J.F. Foley & H.M. Lemon Therapy of malignant APUD cell tumors. Effectiveness of DTIC Cancer 51 5 1983 790-794
21. T. Kurose Y. Seino H. Ishida et al. Successful treatment of metastatic glucagonoma with dacarbazine Lancet 17 1 1984 621-622
22. A.F. Altimari K. Badrinath H.J. Reisel & R.A. Prinz DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors Surgery 102 6 1987 1009-1017
23. R.K. Ramanathan A. Cnaan R.G. Hahn et al. Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282 Ann Oncol 12 8 2001 1139-1143
24. T.L. Van der Loos E.R. Lambrecht & J.C. Lambers Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine J Am Acad Dermatol 16 2 Pt 2 1987 468-472
25. B. Hallengren J.F. Dymling P. Manhem et al. Unsuccessful DTIC treatment of a patient with glucagonoma syndrome Acta Med Scand 213 4 1983 317-318
26. M. Di Bartolomeo E. Bajetta A.M. Bochicchio et al. A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trial in Medical Oncology (I.T.M.O.) Group Ann Oncol 6 1 1995 77-79
27. E. Bajetta L. Rimassa C. Carnaghi et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors Cancer 83 2 1998 372-378
28. R.T. Jensen & G.M. Doherty Carcinoid tumors and the carcinoid syndrome In V.T. Devita S. Hellmann & S.A. Rosenberg (eds.) Principles and Practice of Oncology 6th edn 2001 Lippincott Williams & Wilkins Philadelphia
29. Ch. Moertel J. Ribin M.J. O'Connell & J. Rubin Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome Cancer Treat Rep 70 1986 1459-1460
30. P. Conte & R. Coleman Bisphosphonates in the treatment of skeletal metastases Semin Oncol 31 5 2004 59-63